March 17 (Reuters) - Revelation Biosciences Inc REVB.O:
GEMINI PRIMING ATTENUATES INFLAMMATION IN HUMAN PERIPHERAL BLOOD MONONUCLEAR CELLS
Source text: ID:nBw2N0fGHa
Further company coverage: REVB.O
((Reuters.Briefs@thomsonreuters.com))
March 17 (Reuters) - Revelation Biosciences Inc REVB.O:
GEMINI PRIMING ATTENUATES INFLAMMATION IN HUMAN PERIPHERAL BLOOD MONONUCLEAR CELLS
Source text: ID:nBw2N0fGHa
Further company coverage: REVB.O
((Reuters.Briefs@thomsonreuters.com))
Comments